Navire Pharma

0 followers


Navire Pharma is developing SHP2 inhibitors as effective additions to the therapeutic arsenal for difficult-to-treat cancers.


Org chart

Collapse
Uma Sinha
Chief Scientific Officer, BridgeBio
Pedro J. Beltran
SVP & Head of Biology for Oncology
Carl Dambkowski
Head of Clinical Strategy

Board & advisors

Neil Kumar
Director
Nancy Kohl
Scientific Advisor
Scott Kopetz
Scientific Advisor
Lillian Siu
Scientific Advisor
Kwok-Kin Wong
Scientific Advisor